Getinge is a medical-technology company committed to ensuring that all people and societies have access to the best possible health care. The company supports its customers to meet their challenges in health care and life-sciences institutions by providing knowledge, technology, and resources to achieve optimal clinical outcomes and, ultimately, to save lives. The offering includes products, solutions and service for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing, and life science. Sustainability is an integral part of the organization, and to minimize negative environmental footprint Getinge has made a decision to become CO2-neutral by 2025.
Founded in 1904, Getinge has more than 10 000 employees worldwide, and the products are sold in more than 135 countries. The company has been listed on the Nasdaq Stockholm Large Cap list since 1993. The US is Getinge’s largest market and represents more than 30% of sales and 2 500 employees.
During 2020, Getinge has further deepened the partnerships with hospitals and pharmaceutical companies in the US and around the world to combat COVID-19. The need for advanced intensive-care-unit (ICU) ventilators and extracorporeal-life-support (ECLS) therapy products for hospitals, along with sterile transfer products for the pharmaceutical industry, has been in focus.
US states we’re located in: New Jersey, New York, Colorado, and New Hampshire
Company Website: getinge.com
